Abvc Biopharma Inc Reports Results For The Quarter Ended In September: Earnings Summary

ABVC Biopharma

16/11/2021 24:03

* ABVC Biopharma Inc  ABVC.OQ  reported a quarterly adjusted
loss of 7 cents​​ per share for the quarter ended in September.
The lone analyst forecast for the quarter was for a loss of 4
cents per share.
* Revenue was $99.00 thousand​;  analysts expected $144.00
thousand. 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* ABVC Biopharma Inc shares had risen by 43.7% this quarter and
lost 34.9% so far this year.
* The company reported a quarterly loss of $1.81 million.
* Wall Street's median 12-month price target for ABVC Biopharma
Inc is $9.50 
This summary was machine generated November 16 at 12:03 a.m.
 ​All figures in US dollars unless otherwise stated